- Home
- DPRO vs ANEB Comparison
DPRO vs ANEB Comparison
Compare DPRO & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- ANEB
- Stock Information
- Founded
- DPRO 1998
- ANEB 2020
- Country
- DPRO Canada
- ANEB United States
- Employees
- DPRO N/A
- ANEB N/A
- Industry
- DPRO Aerospace
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- DPRO Industrials
- ANEB Health Care
- Exchange
- DPRO Nasdaq
- ANEB Nasdaq
- Market Cap
- DPRO 36.2M
- ANEB 39.0M
- IPO Year
- DPRO N/A
- ANEB 2021
- Fundamental
- Price
- DPRO $3.12
- ANEB $1.68
- Analyst Decision
- DPRO Strong Buy
- ANEB Strong Buy
- Analyst Count
- DPRO 2
- ANEB 2
- Target Price
- DPRO $5.25
- ANEB $5.50
- AVG Volume (30 Days)
- DPRO 2.5M
- ANEB 17.0K
- Earning Date
- DPRO 08-12-2025
- ANEB 05-13-2025
- Dividend Yield
- DPRO N/A
- ANEB N/A
- EPS Growth
- DPRO N/A
- ANEB N/A
- EPS
- DPRO N/A
- ANEB N/A
- Revenue
- DPRO $4,716,450.00
- ANEB N/A
- Revenue This Year
- DPRO $94.01
- ANEB N/A
- Revenue Next Year
- DPRO $95.14
- ANEB N/A
- P/E Ratio
- DPRO N/A
- ANEB N/A
- Revenue Growth
- DPRO 7.90
- ANEB N/A
- 52 Week Low
- DPRO $1.55
- ANEB $0.80
- 52 Week High
- DPRO $6.09
- ANEB $3.08
- Technical
- Relative Strength Index (RSI)
- DPRO 58.98
- ANEB 65.22
- Support Level
- DPRO $2.96
- ANEB $1.36
- Resistance Level
- DPRO $3.32
- ANEB $2.46
- Average True Range (ATR)
- DPRO 0.29
- ANEB 0.26
- MACD
- DPRO 0.04
- ANEB 0.03
- Stochastic Oscillator
- DPRO 81.48
- ANEB 37.20
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.